Literature DB >> 28653946

The truth on current peritoneal dialysis: state of the art.

R T Krediet1, A C Abrahams, C W H de Fijter, M G H Betjes, W H Boer, B C van Jaarsveld, C J A M Konings, F W Dekker.   

Abstract

The share of peritoneal dialysis (PD) in the spectrum of chronic dialysis has decreased markedly in the Netherlands in the last 15 years. Consequently, the knowledge of nephrologists and nursing staff on PD has declined leading to a negative spiral in which loss of experience resulted in loss of enthusiasm to offer PD to patients and also in less interest in the new PD developments. All these changes took place while the results of PD improved and patient survival was at least similar to that on haemodialysis. The aim of this review is first to give a summary of the principles and practice of patient and staff education and to describe the role of the medical contribution in decision-making. On this basis, the second aim is to update internist-nephrologists on a number of issues that have been underexposed in the past. Recent patient and technique survival data of PD patients is reviewed, and also the new insights into dialysis adequacy. The presence of residual renal function is the main determinant of patient survival together with prevention of overhydration. Urea and creatinine removal are not important at all when patients are still passing urine. Many early problems with PD are due to the peritoneal catheter and suggestions are made for improvement of its function. The prevention and management of infections is reviewed, and also the regular assessment of peritoneal function. Free water transport is a predictor of encapsulating peritoneal sclerosis (EPS), which should be assessed regularly. The pathogenesis of EPS, treatment and the decreasing incidence are discussed.

Entities:  

Mesh:

Year:  2017        PMID: 28653946

Source DB:  PubMed          Journal:  Neth J Med        ISSN: 0300-2977            Impact factor:   1.422


  6 in total

1.  Glucose Exposure in Peritoneal Dialysis Is a Significant Factor Predicting Peritonitis.

Authors:  Herma Uiterwijk; Casper F M Franssen; Johanna Kuipers; Ralf Westerhuis; Ferdau L Nauta
Journal:  Am J Nephrol       Date:  2020-02-18       Impact factor: 3.754

2.  Efficacy and safety of daprodustat in Japanese peritoneal dialysis patients.

Authors:  Hidetoshi Kanai; Masaomi Nangaku; Reiko Nagai; Nobuhiko Okuda; Kyo Kurata; Takashi Nagakubo; Yukihiro Endo; Alexander Cobitz
Journal:  Ther Apher Dial       Date:  2021-05-25       Impact factor: 2.195

3.  Effect of astragaloside IV and the role of nuclear receptor RXRα in human peritoneal mesothelial cells in high glucose‑based peritoneal dialysis fluids.

Authors:  Weiwei Zhu; Xin Zhang; Kun Gao; Xufang Wang
Journal:  Mol Med Rep       Date:  2019-08-22       Impact factor: 2.952

4.  Intermittent Oral Dosing of Roxadustat in Peritoneal Dialysis Chronic Kidney Disease Patients with Anemia: A Randomized, Phase 3, Multicenter, Open-Label Study.

Authors:  Tadao Akizawa; Tetsuro Otsuka; Michael Reusch; Mai Ueno
Journal:  Ther Apher Dial       Date:  2019-07-31       Impact factor: 1.762

5.  Overhydration and low serum prealbumin predict peritoneal dialysis-related peritonitis in continuous ambulatory peritoneal dialysis patients.

Authors:  Quyen Dao Bui Quy; Tuan Pham Ngoc Huy; Loc Nguyen Duc; My Pham Van; Dung Nguyen Huu; Toan Nguyen Duy; Tien Tran Viet; Quyet Do; Thang Le Viet
Journal:  BMC Nephrol       Date:  2020-11-25       Impact factor: 2.388

Review 6.  Peritoneal Dialysis for Potential Kidney Transplant Recipients: Pride or Prejudice?

Authors:  Luca Nardelli; Antonio Scalamogna; Piergiorgio Messa; Maurizio Gallieni; Roberto Cacciola; Federica Tripodi; Giuseppe Castellano; Evaldo Favi
Journal:  Medicina (Kaunas)       Date:  2022-02-01       Impact factor: 2.430

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.